Key considerations for treatment selection and sequencing in patients with RRMM Lessons from real-life clinical practice

touchPANEL DISCUSSION for touchONCOLOGY  Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM. The experts: Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA This touchPODCAST is for HCPs only.  This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME. For further information please visit: https://touchoncology.com/